Novartis Says Authorities Investigating a Patent Assertion
15 Septiembre 2022 - 01:16AM
Noticias Dow Jones
By Joshua Kirby
Novartis AG said Thursday that Swiss competition-authority
officers visited the company's headquarters as part of an
investigation into a patent assertion.
The investigation is being carried out by the Swiss Competition
Commission, or COMCO, in collaboration with the European Union's
executive arm the European Commission, the pharmaceutical company
said.
The investigation, which is looking into Novartis's assertion of
a patent in the broader field of dermatology treatments, doesn't
imply any wrongdoing or financial impact, the company said. COMCO
representatives have visited the company's offices in Basel,
Switzerland, Novartis said, adding that it is cooperating with the
authorities and is confident of clarifying its position.
Write to Joshua Kirby at joshua.kirby@wsj.com;
@joshualeokirby
(END) Dow Jones Newswires
September 15, 2022 02:01 ET (06:01 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Novartis (NYSE:NVS)
Gráfica de Acción Histórica
De Nov 2023 a Dic 2023
Novartis (NYSE:NVS)
Gráfica de Acción Histórica
De Dic 2022 a Dic 2023
